225 related articles for article (PubMed ID: 22891045)
1. TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure.
Boerrigter G; Soergel DG; Violin JD; Lark MW; Burnett JC
Circ Heart Fail; 2012 Sep; 5(5):627-34. PubMed ID: 22891045
[TBL] [Abstract][Full Text] [Related]
2. Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure.
Boerrigter G; Lark MW; Whalen EJ; Soergel DG; Violin JD; Burnett JC
Circ Heart Fail; 2011 Nov; 4(6):770-8. PubMed ID: 21835984
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
4. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
[TBL] [Abstract][Full Text] [Related]
5. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
6. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
7. Furosemide dynamics in conscious rabbits: modulation by angiotensin II.
Homsy W; Marleau S; du Souich P
Cardiovasc Drugs Ther; 1995 Apr; 9(2):311-7. PubMed ID: 7662598
[TBL] [Abstract][Full Text] [Related]
8. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
Onogawa T; Sakamoto Y; Nakamura S; Nakayama S; Fujiki H; Yamamura Y
Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S67-76. PubMed ID: 22120095
[TBL] [Abstract][Full Text] [Related]
9. A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.
McKie PM; Cataliotti A; Boerrigter G; Chen HH; Sangaralingham SJ; Martin FL; Ichiki T; Burnett JC
Hypertension; 2010 Dec; 56(6):1152-9. PubMed ID: 20975033
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
[TBL] [Abstract][Full Text] [Related]
11. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
Vervoort G; Hertenberg F; Wetzels JF; Smits P
J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
[TBL] [Abstract][Full Text] [Related]
12. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
[TBL] [Abstract][Full Text] [Related]
13. Diuretic action of the novel loop diuretic torasemide in the presence of angiotensin II or endothelin-1 in anaesthetized dogs.
Uchida T; Hayashi K; Kido H; Watanabe M
J Pharm Pharmacol; 1992 Jan; 44(1):39-43. PubMed ID: 1350626
[TBL] [Abstract][Full Text] [Related]
14. Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure.
Cataliotti A; Boerrigter G; Chen HH; Jougasaki M; Costello LC; Tsuruda T; Lee SC; Malatino LS; Burnett JC
Circulation; 2002 Feb; 105(5):639-44. PubMed ID: 11827932
[TBL] [Abstract][Full Text] [Related]
15. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
Schnackenberg CG; Merz E; Brooks DP
Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
[TBL] [Abstract][Full Text] [Related]
16. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
17. Effects of atrial natriuretic peptides and furosemide in conscious dogs.
Emmeluth C; Eiken P; Johannessen AC; Bie P
Proc Soc Exp Biol Med; 1987 Oct; 186(1):103-12. PubMed ID: 2957698
[TBL] [Abstract][Full Text] [Related]
18. Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure.
Motwani JG; Fenwick MK; Morton JJ; Struthers AD
Circulation; 1992 Aug; 86(2):439-45. PubMed ID: 1638713
[TBL] [Abstract][Full Text] [Related]
19. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.
Aaser E; Gullestad L; Tølløfsrud S; Lundberg J; Hall C; Djøseland O; Kjekshus J; Forfang K
Scand J Clin Lab Invest; 1997 Jul; 57(4):361-7. PubMed ID: 9249883
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
Swärd K; Valsson F; Sellgren J; Ricksten SE
Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]